首页 | 本学科首页   官方微博 | 高级检索  
     


The pathology of cervical cancer
Authors:M C Anderson
Affiliation:1. Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom;2. Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, United Kingdom;3. Center for Research on Genomics and Global Health, National Human Genome Research Institute, Bethesda, MD, USA;4. Institute of Human Virology, Abuja, Nigeria;5. Department of Epidemiology and Public Health, University of Maryland, Baltimore, USA;6. National Hospital Abuja, Nigeria;7. University of Abuja Teaching Hospital Gwagwalada, Nigeria;8. University of Nigeria Teaching Hospital Enugu, Nigeria;9. International Agency for Research on Cancer, Lyon, France;10. Federal Ministry of Health, Abuja, Nigeria;11. Marlene and Stewart Greenbaum Comprehensive Cancer Center and Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA;1. Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland;2. Department of Clinical Sciences, University of Central Florida College of Medicine, Orlando, Florida;3. Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah;4. Department of Pathology, PeaceHealth Southwest Medical Center, Vancouver, Washington;5. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;6. Department of Pathology, University of North Carolina Hospital, Chapel Hill, North Carolina;7. College of American Pathologists, Northfield, Illinois;8. Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin;9. Department of Pathology, University of Rochester, Rochester, New York;10. Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio;11. Biostatistics Department, College of American Pathologists, Northfield, Illinois;12. Department of Pathology, University of California, San Francisco, and San Francisco Veterans Affairs HealthCare System, San Francisco, California;13. Divisions of Gynecology and Breast Pathology and Cytopathology, Joint Pathology Center, Silver Spring, Maryland;1. University of Utah School of Medicine, Salt Lake City, UT, USA;2. University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA;3. University of Utah, Department of Obstetrics & Gynecology, Salt Lake City, UT, USA;4. University of Utah, Department of Internal Medicine, Salt Lake City, UT, USA;1. Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea;2. Department of Obstetrics and Gynecology, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea;3. Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea;4. Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea;5. Clinical Omics Research Center, School of Medicine, Kyungpook National University, Daegu, Republic of Korea;2. Abdominal Imaging, Diagnostic Radiology, UTMDACC, Houston, TX
Abstract:
The preinvasive phase of squamous cell carcinoma of the cervix is a continuous spectrum of abnormal epithelium, which, for convenience of classification and as a guide to management, is customarily subdivided into three grades. The histological diagnosis of CIN, as well as the distinction between the grades, depends on a combination of features embracing aspects of differentiation, nuclear changes and mitotic activity. Grading of CIN is subjective. Generally, a minor degree of CIN would be expected to progress to a more severe form if not treated, but this progression does not seem to be inevitable; the more severe a CIN is at the time of diagnosis, the more likely it is that it will progress, both to a more severe degree of CIN and, eventually, to invasive carcinoma. Conversely, the more minor the degree of CIN at diagnosis, the more likely it is that it will regress. True figures are not available for the rate of progression from CIN to invasive carcinoma; it is sufficient to accept that the risk of progression probably occurs in a significant proportion of cases, if not the majority. Preclinical invasive carcinoma is divided into microinvasive carcinoma and occult invasive (Stage Ib) carcinoma. The definitions of these lesions have not yet been satisfactorily established; the term microinvasive carcinoma should define the maximum size of tumour which has virtually no metastatic potential and so may be treated in a conservative fashion. Invasive squamous cell carcinoma is classified histologically according to the cell type and the degree of differentiation, although it is debatable whether the cell type has any correlation with prognosis. Adenocarcinomas make up 5-10% of cervical cancers and a variety of histological types have been recognized. Adenocarcinoma in situ is being diagnosed with increasing frequency, often in association with squamous CIN. It seems apparent that AIS is a precursor of adenocarcinoma, but little is known about its natural history.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号